Dr. Krishna C. Alluri
Claim this profileProvidence Portland Medical Center
Studies Ovarian Carcinoma
Studies Ovarian Cancer
26 reported clinical trials
63 drugs studied
Area of expertise
1Ovarian Carcinoma
Stage I
Stage IV
Stage II
2Ovarian Cancer
BRCA1 positive
Stage IV
Stage II
Affiliated Hospitals
Clinical Trials Krishna C. Alluri is currently running
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting2 awards Phase 326 criteria
Sentinel Lymph Node Biopsy vs Neck Dissection
for Oral Cancer
This phase II/III trial studies how well sentinel lymph node biopsy works and compares sentinel lymph node biopsy surgery to standard neck dissection as part of the treatment for early-stage oral cavity cancer. Sentinel lymph node biopsy surgery is a procedure that removes a smaller number of lymph nodes from your neck because it uses an imaging agent to see which lymph nodes are most likely to have cancer. Standard neck dissection, such as elective neck dissection, removes many of the lymph nodes in your neck. Using sentinel lymph node biopsy surgery may work better in treating patients with early-stage oral cavity cancer compared to standard elective neck dissection.
Recruiting1 award Phase 2 & 3
More about Krishna C. Alluri
Clinical Trial Related5 years of experience running clinical trials · Led 26 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Krishna C. Alluri has experience with
- Cisplatin
- Atezolizumab
- Carboplatin
- Intensity-Modulated Radiation Therapy
- Radiation Therapy
- Nivolumab
Breakdown of trials Krishna C. Alluri has run
Ovarian Carcinoma
Ovarian Cancer
Endometrial Adenocarcinoma
Uterine Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Krishna C. Alluri specialize in?
Krishna C. Alluri focuses on Ovarian Carcinoma and Ovarian Cancer. In particular, much of their work with Ovarian Carcinoma has involved Stage I patients, or patients who are Stage IV.
Is Krishna C. Alluri currently recruiting for clinical trials?
Yes, Krishna C. Alluri is currently recruiting for 6 clinical trials in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Krishna C. Alluri has studied deeply?
Yes, Krishna C. Alluri has studied treatments such as Cisplatin, Atezolizumab, Carboplatin.
What is the best way to schedule an appointment with Krishna C. Alluri?
Apply for one of the trials that Krishna C. Alluri is conducting.
What is the office address of Krishna C. Alluri?
The office of Krishna C. Alluri is located at: Providence Portland Medical Center, Portland, Oregon 97213 United States. This is the address for their practice at the Providence Portland Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.